Article Sidebar

Submitted
Apr 26, 2021
Published
Apr 26, 2021
Download
PDF
Statistic
Read Counter : 38 Download : 28

Main Article Content

Abstract

Current review was regarding the thyroid gland disorder in those patients who are suffering with Type II Diabetes mellitus. Many studies were conducted regarding endocrine disorders. This review highlights the prevalence of thyroid disorder and its complications if it’s not been treated at the correct stage. Current review details the underlying mechanism of thyroid dysfunction in people with type II diabetes mellitus and its reason. As thyroid dysfunction was asymptomatic in early stages, majority of the people neglects testing of thyroid biomarkers. As it increases it exposes in the form of clinical manifestations such as pigmentation, constipation, hives, weight gain/loss, loss of appetite, gray hair, unusual fatigue, tiredness increases. As it’s a common fact that every individual knew thyroid was   non-curable only maintenance was needed for lifelong. But where coming to the people with diabetes mellitus the condition was worsening, it leads to further complications and due to unknown reason in most of the patient’s thyroid will be uncontrolled and in half of the patient’s diabetes will leads to asymptomatic dysfunctioning of thyroid gland which is known as autoimmune disease.

Keywords

Biomarkers Hypothyroidism Hyperthyroidism Diabetes mellitus Prevalence

Article Details

How to Cite
Lakshmi I, Prasanth S, Sagarika BH, Keerthy J, Sattanathan K, & Sambathkumar R. (2021). Review on rise of sister disease in type-II Diabetic patients. International Journal of Research in Pharmacology & Pharmacotherapeutics, 4(4), 416-421. https://doi.org/10.61096/ijrpp.v4.iss4.2015.416-421
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Brenta G. Diabetes and thyroid disorders. Br J Diabetes Vasc Dis. 2010; 10: 172–77.
  2. [2]. Chen HS, Wu TE, Jap TS, Lu RA, Wang ML, Chen RL, et al., Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients. Diabetes Med. 2007; 24(12): 1336-44.
  3. [3]. Uzunlulu M, Yorulmaz E, Oguz A. Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. J Endocrinol. 2007; 54: 71-76.
  4. [4]. IDF Diabetes Atlas 6th edition; 2014 update.
  5. [5]. Turnbridge WMJ, Evered DC. The spectrum of thyroid disease in a community: The Wickham survey J Clin Endocrinol. 1977; 7: 481-93.
  6. [6]. Junik R, Kozinski M. Thyroid ultrasound in Diabetic Patients without overt thyroid disease. Acta Radiologica. 2006; 47: 687-91.
  7. [7]. Park YS, Kim TW. Increased prevalence of autoimmune thyroid disease in patients with type I Diabetes. Korean J Intern Med. 2000; 15: 202-10.
  8. [8]. Menon PS, Vaidyanathan B. Autoimmune thyroid disease in Indian children with Type 1 diabetes mellitus. JPEM. 2001; 14: 279-86.
  9. [9]. Matejkova M, Zamrazil V. Autoimmune thyroiditis in non-obese subjects with initial diagnosis of Type 2 diabetes mellitus. J Endocrinol Invest. 2002; 25: 779-84.
  10. [10]. Papazafiropoulou A. Prevalence of thyroid dysfunction in Greek Type 2 diabetic patients attending an outpatient clinic. JCMR. 2010; 2: 75-8.
  11. [11]. Swamy RM, Naveen Kumar, Srinivasa K, Manjunath GN, Prasad Byrav DS, Venkatesh G. Evaluation of hypothyroidism as a complication in Type II Diabetes Mellitus. Int J Biomed Res. 2012; 23:170-72.
  12. [12]. Raboudi N, Arem R, Jones RH, Chap Z, Pena J, Chou J, et al., Fasting and post absorptive hepatic glucose and insulin metabolism in hyperthyroidism. Am J Physiol Endocrinol Metab. 1989; 256: 159–66.
  13. [13]. Weinstein SP, Boyle E, Fisher M, Haber RS. Regulation of GLUT2 glucose transporter expression in liver by thyroid hormone: evidence for hormonal regulation of the hepatic glucose transport system. J Endocrinol. 1994; 135: 649-54.
  14. [14]. Viguerie N, Millet L, Avizou S, Vidal H, Larrouy D and Langin D. Regulation of human adipocyte gene expression by thyroid hormone. J Clin Endocrinol Metab. 2002; 87: 630–34.
  15. [15]. Clement K, Viguerie N, Diehn M, Alizadeh A, Barbe P, Thalamas C, et al., In Vivo Regulation of Human Skeletal Muscle Gene Expression by Thyroid Hormone. Genome Researc. 2002; 12: 281-29.
  16. [16]. Rochon C, Tauveron I. Response of glucose disposal to hyper insulinemia in human hypothyroidism and hyperthyroidism. J Clin Sci. 2003; 104: 7-15.
  17. [17]. Handisurya A, Pacini G. Effects of thyroxin replacement therapy on glucose metabolism in subjects with subclinical and overt hypothyroidism. J Clin Endocrinol. 2008; 69: 963-69.
  18. [18]. Muller MJ, Paschen U, Seitz HJ. Thyroid hormone regulation of glucose homeostasis in the miniature pig. J Endocrinol. 1983; 112: 2025-31.
  19. [19]. Okajima F, Ui M. Metabolism of glucose in hyper and hypothyroid rats in vivo. Glucose turn over values and futile cycle activities obtained with 14C and 3H labelled glucose. J Bio chem. 1979; 182: 565-75.
  20. [20]. Mculloch AJ, Nosadini R, Pernet A, Piniewska M, Cook DB, Clark F, et al. Glucose turnover and indices of recycling in thyrotoxicosis and primary thyroid failure. Clinical Science. Asian J Med Sci. 2015: 6; 38
  21. [21]. Ravishankar SN, Champakamalini, Venkatesh, Mohsin. A prospective study of thyroid - dysfunction in patients with Type 2 diabetes in general population. Archives of Medicine. 2013; 5: 1-2
  22. [22]. Schlienger JL, Anceau A, Chabrier G, North ML, Stephan F. Effect of diabetic control on the level of circulating thyroid hormones. Diabetologia. 1982; 22: 486-8.
  23. [23]. Donckier JE. Endocrine diseases and diabetes. In: Text book of Diabetes mellitus. Pickup JC, Williams G (editors), Blackwell Publishing Company, Chichester. 2003; 27: 27.25.
  24. [24]. Kalmann R, Mourits M. Diabetes Mellitus: a risk factor in patients with Grave’s orbitopathy. Br J Ophthalmol. 1999; 83: 463-5.
  25. [25]. Taylor R, Muculloch A, Zeuzem S, Gray P, Clark F, Alberti G. Insulin secretion, adipocyte insulin binding and insulin sensitivity in thyrotoxicosis. Acta Endorcinol. 1985; 109: 96-103.
  26. [26]. Ahren B, Lundquist I, Hedner P, Valdemassan S, Scheroten B. Glucose tolerance and insulin and C Peptide responses after various insulin secretions stimuli in hyperthyroid and hypothyroid subjects after treatment. Diab Res Clin Practice. 1985; 23: 95- 103.
  27. [27]. Dimitriadis G, Baker B, Marsh H. Effect of thyroid hormone excess on action, secretion and metabolism of insulin in humans. Am J Physiol. 1985; 248: 593- 601.
  28. [28]. Randin J, Tappy L, Scazziga B, Jequier E, Felber J. Insulin sensitivity and exogenous insulin clearance in Grave’s disease. Measurements by the glucose clamp technique and continuous glucose calorimetry. J Diabetes. 1986; 35: 178-81.
  29. [29]. Bech K, Damsbo P, Eldrup E. Beta cell function and glucose and lipid oxidation in Grave’s disease. Clin Endocrinol. 1996; 44: 59-66.
  30. [30]. Dimitriadis G, Raptis SA. Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes. 2001; 109: 225-39.
  31. [31]. Holness M, Sugden M. Continued glucose output after refeeding contributes to glucose intolerance in thyroid disease. J Bio chem. 1987; 247: 801-4.
  32. [32]. Mokuno T, Uchimura K, Hayashi R, et al. Glucose transporter concentration in hyper and hypothyroid rat livers. J Endocrinol. 1999; 160: 285-9.
  33. [33]. Haber R, Wilson C, Weinstein S, Pritsker A, Cushman S. Thyroid hormone increases the partitioning of glucose transporters to the plasma membrane in ARL 15 cells. Amer J Physiol. 1995; 269: 605-10.
  34. [34]. Dimitriadis G, Parry Billings M, Bevan S. The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Eur J Clinical Invest. 1997; 27: 475-83.
  35. [35]. Mohn A, Di Michele S, Di Luzio R, Tumini S, Chiarelli F. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus. Diab Med. 2002; 19; 70-3.
  36. [36]. Bergesio F, Bandini S, Cresci B. Hyperthyroidism: Is it really the major factor affecting glucose tolerance in ureamia. Electrolyte Metab. 1996; 22: 187-91.
  37. [37]. Bando U, Ushiogi Y, Toya D, Tahaka N, Fujisawa M. Diabetic nephropathy accompanied by iodine induced nonautoimmune primary hypothyroidism: two cases report. Endocrinol J. 1999; 46: 803-10.
  38. [38]. Hilton CW, Mizuma H, Svec F, Prasad C. Relationship between plasma Clyco (His-Pro), a neuropeptide common to processed protein foods and C-peptide/insulin molar ratio in obese woman. Nutr Neurosci. 2001; 4: 469-74.
  39. [39]. Kahn RC, Catanese VM, Becker KL, Bilezikian JP, Bremna JW, Hung W,Kahn CR, Lnuix DL, Reb RW, Robertson G L, Wartofski L, editors. Secondary forms of diabetes mellitus.Principles and practice of endocrinology and metabolism. Philadelphia: JP Lippincott Company; 1990: 1087-93.
  40. [40]. Mayne PD: editor. Carbohydrate metabolism. Clinical chemistry in diagnosis and treatment. 6th edition Glasgow, Barth: Colourbooks; 1998: 195-222.
  41. [41]. Dias C M, Nogueira P, Rosa AN, De Sa JV, Gouvea MF, Mannho Falcos CM. Total cholesterol and high-density cholesterol in patients with insulin dependent diabetes mellitus. Acta Medica. 1995; 8: 619-28.
  42. [42]. Granner DK. Thyroid hormones. In Murray R.K, Granner DK, Mayes PA, Rodwell VW. editors. Harper’s Biochemistry, 25th edition. London, Prentice-Hall International Inc. 2000; 533-38.
  43. [43]. Erasmus RT, Fakeye T, Olukoga O. Prevalence of diabetes in Nigerian Population. Transac Royal Society Trop Med & Hyg. 1989; 83: 417-8.
  44. [44]. Bharat, Davina Hijam, David Gangte, Lalnunpui, Premchand, Ibetombi Devi, Gyaneshwar W. Thyroid Status in Diabetes Mellitus. J Glycomics Lipidomics. 2013; 3: 1-4.
  45. [45]. Der EM, Quayson SE, Clegg Lamptey JN, Wiredu EK, Ephraim RK .Thyroid disorders in Accra, Ghana: A Retrospective Histopathological study at the Korle-Bu Teaching Hospital. J Med Biomed Sci. 2013; 2: 1-7.
  46. [46]. Ghazali S, Abbiyesuku F. Thyroid dysfunction in Type 2 diabetics seen at the University College Hospital, Ibadan, Nigeria, Nigerian. J Physiolo Sci. 2010; 25: 173-79.
  47. [47]. Gurjeet Singh, Vikas Gupta, Anu Kumar Sharma, Neeraj Gupta. Evaluation of Thyroid Dysfunction Among Type 2 Diabetic Punjabi Population. Adv Bio res. 2011; 2: 3-9.
  48. [48]. Chaoxun Wang. The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases. J Diabetes Res. 2013; 2: 33-8.
  49. [49]. Vinu Vij, Pallavi Chitnis, Vijay Kumar Gupta. Evaluation of Thyroid Dysfunction among type II diabetic patients. Int J Pharm Biologic Sci. 2012; 2: 150-55.